Paxil: Restore Emotional Balance with Trusted SSRI Therapy

Paxil
| Product dosage: 20mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $2.03 | $61.00 (0%) | 🛒 Add to cart |
| 60 | $1.32 | $122.00 $79.00 (35%) | 🛒 Add to cart |
| 90 | $1.08 | $183.00 $97.00 (47%) | 🛒 Add to cart |
| 120 | $0.96 | $244.00 $115.00 (53%) | 🛒 Add to cart |
| 180 | $0.84 | $366.00 $152.00 (58%) | 🛒 Add to cart |
| 270 | $0.76 | $549.00 $206.00 (62%) | 🛒 Add to cart |
| 360 | $0.72
Best per pill | $732.00 $260.00 (64%) | 🛒 Add to cart |
| Product dosage: 30mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $2.13 | $64.00 (0%) | 🛒 Add to cart |
| 60 | $1.45 | $128.00 $87.00 (32%) | 🛒 Add to cart |
| 90 | $1.22 | $192.00 $110.00 (43%) | 🛒 Add to cart |
| 120 | $1.10 | $256.00 $132.00 (48%) | 🛒 Add to cart |
| 180 | $0.99 | $384.00 $178.00 (54%) | 🛒 Add to cart |
| 360 | $0.87
Best per pill | $768.00 $313.00 (59%) | 🛒 Add to cart |
| Product dosage: 40mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $2.23 | $67.00 (0%) | 🛒 Add to cart |
| 60 | $1.68 | $134.00 $101.00 (25%) | 🛒 Add to cart |
| 90 | $1.50 | $201.00 $135.00 (33%) | 🛒 Add to cart |
| 120 | $1.42 | $268.00 $170.00 (37%) | 🛒 Add to cart |
| 180 | $1.33 | $402.00 $239.00 (41%) | 🛒 Add to cart |
| 360 | $1.24
Best per pill | $804.00 $445.00 (45%) | 🛒 Add to cart |
Synonyms | |||
Paxil (paroxetine hydrochloride) is a selective serotonin reuptake inhibitor (SSRI) antidepressant medication clinically proven to manage symptoms of major depressive disorder, anxiety disorders, and related conditions. Developed through rigorous pharmaceutical research, it works by increasing serotonin levels in the brain, helping restore chemical balance to improve mood, reduce anxiety, and enhance overall mental well-being. Trusted by healthcare professionals worldwide, Paxil represents a cornerstone in modern psychopharmacology with established efficacy and a well-documented safety profile when used as prescribed under medical supervision.
Features
- Contains paroxetine hydrochloride as the active pharmaceutical ingredient
- Available in immediate-release tablets (10 mg, 20 mg, 30 mg, 40 mg) and controlled-release formulations
- Manufactured under strict quality control standards complying with FDA regulations
- Bioequivalent to reference listed drug with consistent pharmacokinetic profile
- White, film-coated tablets with distinct identification markings for dosage verification
- Stable shelf life of 24 months when stored in original packaging at recommended conditions
Benefits
- Effectively reduces symptoms of depression including low mood, loss of interest, and fatigue
- Demonstrates significant anxiolytic properties for various anxiety disorders
- Helps restore normal sleep patterns and improves overall quality of life
- Provides gradual and sustained mood stabilization with continuous use
- Reduces frequency and intensity of panic attacks in diagnosed patients
- Improves social and occupational functioning through symptom management
Common use
Paxil is primarily indicated for the treatment of major depressive disorder (MDD) in adults, characterized by persistent depressed mood, loss of interest in activities, changes in appetite or sleep patterns, decreased energy, feelings of worthlessness, and difficulty concentrating. It is also FDA-approved for panic disorder, social anxiety disorder, generalized anxiety disorder, obsessive-compulsive disorder, and post-traumatic stress disorder. Off-label uses may include premenstrual dysphoric disorder and vasomotor symptoms associated with menopause, though these applications require careful medical supervision and individualized risk-benefit assessment.
Dosage and direction
Initial dosing for depression typically begins at 20 mg once daily, preferably in the morning with food to minimize gastrointestinal discomfort. Dosage may be adjusted in 10 mg increments at intervals of at least one week based on therapeutic response and tolerability, with maximum recommended dose of 50 mg daily for depression and 60 mg daily for obsessive-compulsive disorder. For panic disorder, initial dose is often lower (10 mg daily) to minimize initial anxiety activation. Controlled-release formulations allow once-daily dosing without regard to meals. Patients should be advised that therapeutic effect may take 4-6 weeks to become fully apparent and should not discontinue medication abruptly without medical guidance.
Precautions
Patients should be monitored closely for clinical worsening, suicide risk, and unusual changes in behavior, especially during initial treatment and dosage adjustments. Caution is advised in patients with history of mania/hypomania, seizure disorders, or angle-closure glaucoma. Regular assessment of renal and hepatic function is recommended in patients with pre-existing conditions. Use with caution in elderly patients due to potential increased sensitivity and higher risk of hyponatremia. Patients should avoid alcohol consumption during treatment due to potential additive CNS effects. Abrupt discontinuation may lead to withdrawal symptoms including dizziness, sensory disturbances, agitation, anxiety, nausea, and sweating.
Contraindications
Paxil is contraindicated in patients taking monoamine oxidase inhibitors (MAOIs) or within 14 days of discontinuing MAOI therapy due to risk of serotonin syndrome. Concomitant use with thioridazine or pimozide is contraindicated due to potential QT prolongation. Contraindicated in patients with known hypersensitivity to paroxetine or any component of the formulation. Not recommended during pregnancy unless potential benefits justify potential risks to the fetus, particularly during first trimester due to possible cardiac malformations. Avoid use in patients with uncontrolled narrow-angle glaucoma.
Possible side effect
Common side effects (≥1%) include nausea, somnolence, insomnia, dizziness, asthenia, constipation, diarrhea, dry mouth, sweating, and decreased appetite. Sexual dysfunction including decreased libido, delayed ejaculation, and anorgasmia may occur. Weight changes (both gain and loss) have been reported. Less frequent but potentially serious adverse effects include serotonin syndrome, abnormal bleeding, hyponatremia, angle-closure glaucoma, and bone fractures. SSRI discontinuation syndrome may occur upon abrupt cessation. Most side effects are dose-dependent and often diminish with continued therapy.
Drug interaction
Paroxetine is a potent inhibitor of CYP2D6 isoenzyme and may increase concentrations of drugs metabolized by this pathway including tricyclic antidepressants, antipsychotics, antiarrhythmics, and beta-blockers. Concomitant use with serotonergic drugs (tramadol, triptans, other antidepressants) increases serotonin syndrome risk. NSAIDs and anticoagulants may increase bleeding risk. May decrease efficacy of tamoxifen through CYP2D6 inhibition. Interactions with drugs highly protein-bound may occur due to displacement from binding sites. Dose adjustment may be necessary when co-administered with cimetidine.
Missed dose
If a dose is missed, it should be taken as soon as remembered unless it is close to the time for the next scheduled dose. In that case, the missed dose should be skipped and the regular dosing schedule resumed. Patients should not take double or extra doses to make up for a missed dose. Consistent daily administration at approximately the same time each day maintains stable plasma concentrations and optimizes therapeutic effect. Setting daily reminders or using pill organizers can help maintain adherence to prescribed regimen.
Overdose
Symptoms of overdose may include nausea, vomiting, drowsiness, sinus tachycardia, dilated pupils, and dizziness. Severe overdose may lead to serotonin syndrome, seizures, coma, or ECG changes including QT prolongation. There is no specific antidote for paroxetine overdose. Management involves supportive care with monitoring of vital signs and cardiac function. Gastric lavage may be considered if presented early after ingestion. Activated charcoal may be administered. Forced diuresis, dialysis, and hemoperfusion are not effective due to high protein binding and large volume of distribution.
Storage
Store at controlled room temperature 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C and 30°C (59°F and 86°F). Keep in original container with lid tightly closed to protect from moisture and light. Keep out of reach of children and pets. Do not transfer tablets to other containers as this may affect stability. Do not use if tablets show signs of discoloration, cracking, or other physical changes. Properly dispose of expired or unused medication through drug take-back programs or according to FDA guidelines.
Disclaimer
This information is provided for educational purposes only and does not constitute medical advice. Individual response to medication may vary. Paxil is a prescription medication that should be used only under the supervision of a qualified healthcare professional. Patients should not make any changes to their medication regimen without consulting their prescribing physician. The complete prescribing information should be reviewed before initiating therapy. Only a healthcare professional can determine the appropriate treatment based on individual medical history, current condition, and risk factors.
Reviews
Clinical studies demonstrate Paxil’s efficacy with response rates of 60-70% in major depressive disorder and significant improvement in anxiety scales for anxiety disorders. Many patients report improved mood, reduced anxiety, and better functional capacity after 4-8 weeks of treatment. Some users note initial side effects that often diminish over time, while others report persistent sexual side effects or weight changes. Long-term users frequently describe maintained therapeutic benefit with stable dosing. Healthcare providers generally consider Paxil an effective option within the SSRI class, particularly for patients with comorbid anxiety features, though individual response varies and requires careful monitoring and dosage adjustment.
